|Articles|May 1, 2000

Advances in the Treatment of GERD: A Managed Care Perspective
Volume 6
Issue 9 Suppl

A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Author(s)Rosemary R. Berardi, PharmD, FASHP

Download PDF: A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Articles in this issue

almost 26 years ago

Article

Participating Faculty

almost 26 years ago

Article

Introduction

almost 26 years ago

Article

An Overview of Gastroesophageal Reflux Disease

almost 26 years ago

Article

New Therapeutic Options in the Treatment of Gastroesophageal Reflux Disease and Other Acid-Peptic Diseases

almost 26 years ago

Article

Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

almost 26 years ago

Article

Treatment of Gastroesophageal Reflux Disease in a Managed Care Environment

almost 26 years ago

Article

Roundtable Discussion

almost 26 years ago

Article

Selected Abstracts

almost 26 years ago

Article

Continuing Medical/Pharmacy Education Quiz

almost 26 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making